A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

Recruiting now

Conditions studied: Glioblastoma

In brief

BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.

Key facts

Study ID

NCT07173829

Run by

University Hospital, Bordeaux

People needed

45

Starts

2025-10-22

Expected to finish

2031-10-01

Last updated by the study team

2026-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery
• Planned surgical tumor resection,
• No objection to participate in research
• Signed genetic consent

You may not qualify if…

• Patients under guardianship, curatorship or protective supervision
• Taking immunosuppressants
• Pregnant or breast-feeding women
• Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care

Where it is running

• CHU de Bordeaux — Bordeaux, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.